COVID-19 Guidance 

Federal Award Management Guidance in Response to COVID-19

It is extremely important that any actions taken in the application for or management of an award are done under the published guidance of the awarding agency. Below is a summary of agency notices most likely to affect applicants and award recipients at the University of Colorado Denver Anschutz Medical Campus. For questions relating to sponsors not listed below, please reach out directly to your PreAward Grants Consultant or department administrators as appropriate. Agencies continue to release updates, and we recommend visiting each agency’s COVID-19 homepage for the most recent guidance. A list of the most recent government agency guidance is also provided by the Council on Government Relations.

National Institutes of Health (NIH)

NIH COVID-19 Home Page

NIH COVID-19 FAQs

General FAQ Proposal Submission and Management Related to COVID-19, NOT-OD-20-083

Flexibilities Available to Applicants and Recipients, NOT-OD-20-086

Guidance for NIH Funded Clinical Trials and Human Subjects Studies, NOT-OD-20-087 

Flexibilities for Assured Institutions for Activities of IACUCs Due to COVID-19, NOT-OD-20-088 

National Science Foundation (NSF)

NSF COVID-19 Homepage

NSF Implementation of Administrative Relief Guidance

FAQs About COVID-19 for NSF Applicants and Awardees 

Impact on Existing Deadlines Dates

Agency for Healthcare Research Quality (AHRQ)

AHRQ COVID-19 Homepage

NOT-HS-20-010 Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by COVID-19

Centers for Disease Control and Prevention (CDC)

CDC COVID-19 Homepage

FAQs

Substance Abuse and Mental Health Services Administration (SAMHSA)

COVID-19 Information for SAMHSA Discretionary Grant Recipients

FAQs

Department of Defense

Basic Research Directorate COVID-19 FAQ 

CDMRP COVID-19 Homepage

USAMRAA COVID-19 Resources

USAMRAA Supplemental Guidance

DARPA COVID-19 Guidance

DARPA FAQs

AFOSR Memo to Grantees

Navy Engaging the Research and Development Industrial Base during Covid-19

ONR Covid-19 Resources

    Department of Health and Human Services (non-CDC/AHRQ/SAMHSA/NIH)

    FDA:  Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

    Office of the Assistant Secretary for Health:  Administrative Relief for Recipients of Federal Financial Assistance Directly Impacted COVID-19

    Non-Federal Guidance

    Alzheimer’s Association COVID-19 Update (PDF)

    American Heart Association – COVID-19

    American Heart Association – Notice to AHA Research Community Regarding COVID-19 – 4.7.20

    Changes in 2020 V Foundation Grant Programs due to COVID 19 Pandemic (PDF)

    Foundation for Anesthesia Education and Research Newsletter – March 2020 (PDF)

    James S. McDonnell Foundation – Dear Grantee Letter

    John Templeton Foundation – Message to Grantees and Applicants on COVID-19

    Juvenile Diabetes Research Foundation – Dear Investigator letter 3.27.20

    Lupus Therapeutics on COVID-19 (PDF)

    Mathers Foundation Grants and COVID-19 Impact

    V Foundation Policy-Administrative Flexibilities due to COVID-19 Disruptions

    Robert Wood Johnson Foundation – COVID-19